Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-10

Clinical Trial Update: INulin-type Fructans-induced Gut Microbiota Modulation Impact on GUT-SKIN Axis Parameters in Psoriasis [NA]

View source ↗

Summary

A completed clinical trial evaluating whether INulin-type Fructans modulate gut microbiota and the gut-skin axis parameters in psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inulin-type Fructans (inulin-type fructans)

Snippet

Sponsor: Polish Academy of Sciences | Conditions: Psoriasis | NA | Status: COMPLETED